Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Cardior Pharmaceuticals has raised €64M across 1 funding round from 9 investors, most recently a Series B round in Aug 2021. Based in Hanover, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-25 | Series B |
| €64M |
| BioMedPartners,Bristol Myers Squibb,Coparion,Fund plus,Hadean Ventures,High-Tech Gründerfonds+3 more |
| View deal → |
